complement factor H
Last updated 3 Apr 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The CFH gene provides instructions for making a protein called complement factor H. This protein helps regulate a part of the body's immune response known as the complement system. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger an inflammatory response, and remove debris from cells and tissues. This system must be carefully regulated so it targets only unwanted materials and does not damage the body's healthy cells. Complement factor H, together with several related proteins, protects healthy cells by preventing the complement system from being turned on (activated) when it is not needed.
Video picks for GenesVideo library
Normal function
The CFH gene provides instructions for making a protein called complement factor H. This protein helps regulate a part of the body's immune response known as the complement system. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger an inflammatory response, and remove debris from cells and tissues. This system must be carefully regulated so it targets only unwanted materials and does not damage the body's healthy cells. Complement factor H, together with several related proteins, protects healthy cells by preventing the complement system from being turned on (activated) when it is not needed.
Conditions referring to this gene or chromosome
Other names
age-related maculopathy susceptibility 1
AHUS1
ARMD4
ARMS1
beta-1-H-globulin
beta-1H
C3b inactivator accelerator
CFAH_HUMAN
CFHL3
factor H
factor H-like 1
FH
FHL1
H factor 1 (complement)
H factor 2 (complement)
HF
HF1
HF2
HUS
MGC88246
Patient picks for Genes

Treatment and medication
Complementary and alternative medicine
Complementary and alternative medicine (CAM) is used by many people. It can have a very good effect on improving well-being and may be helpful in relieving some symptoms. However, although there is some evidence from clinical studies that CAMs may work for certain symptoms, the evidence is not very strong and it is impossible to draw firm conclusions about the benefits of each treatment. It is very important to consider whether any CAM treatment may have side-effects. Again the side-effects of some CAM treatments, particularly some herbal remedies, are not as well known as for conventional medicines. In addition, choosing to use alternative medicine instead of medically recommended treatments can sometimes be dangerous.
by Dr Hayley Willacy, FRCGP

Cancer
Breast cancer facts and risk factors
Most cases of breast cancer occur by chance. However, breast cancer does occur more often than usual in some families because of their genetic makeup.
by Dr Colin Tidy, MRCGP

Heart health and blood vessels
Dilated cardiomyopathy causes: what are the risk factors?
Having dilated cardiomyopathy means that your heart muscle is weakened, which affects how your heart pumps blood around your body. There are a wide range of dilated cardiomyopathy causes, including genetics, other health conditions, alcohol consumption and a poor diet. While we can't control some of these risk factors, we can make positive lifestyle changes to reduce our risk of developing dilated cardiomyopathy.
by Amberley Davis

Treatment and medication
What factors are causing antimicrobial resistance?
Following a recent study by health economists at the University of Manchester and the University of Southern Denmark, the tremendous pressure GPs are currently working under has been linked to increasing broad-spectrum antibiotic prescribing in England. Because excess antibiotic prescribing has been closely linked to antibiotic resistance, there are concerns that these higher prescribing levels may be contributing to antimicrobial resistance.
by Emily Jane Bashforth

Medicine
Hydroxocobalamin injection
Hydroxocobalamin is used to treat some types of anaemia. It is given by injection into a muscle. Treatment with hydroxocobalamin is usually lifelong.
by Michael Stewart, MRPharmS

Type 1 diabetes
Is type 1 diabetes hereditary?
Dr Partha Kar Although type 1 diabetes is not an inherited disease, there is some genetic factor. A first-degree relative (sister, brother, son, daughter) of someone with type 1 diabetes has about a 1 in 16 chance of developing type 1 diabetes. For more information on type 1 diabetes, go to [https://patient.info/health/type-1-diabetes](https://patient.info/health/type-1-diabetes)
by Dr Partha Kar, FRCP
Related patient information and medicines

Patient information leaflet
Vitamin B12 deficiency and pernicious anaemia
It’s an essential nutrient that the body needs but cannot produce on its own, so it must be obtained through diet or supplements. Vitamin B12 is primarily involved in the production of red blood cells, the maintenance of a healthy nervous system, including brain function, and releasing energy from food. Vitamin B12 deficiency anaemia occurs when a.

Patient information leaflet
Haemophilia
Haemophilia is a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have.

Patient information leaflet
Can I take Ciprofloxacin and Doxycycline together?
Taking ciprofloxacin and doxycycline together may slightly increase the risk of side effects, such as skin sensitivity to sunlight or digestive upset. ...your prescriptions, over-the-counter medicines, and supplements are safe to take togetherAlways consult your GP, pharmacist, or another qualified healthcare professional before making decisions.

Patient information leaflet
Can I take Apixaban and Bisoprolol together?
There is no direct interaction between apixaban and bisoprolol. They work in different ways and do not interfere with how the body processes each other. Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood.

Patient information leaflet
Retinal vein occlusion
Conditions which increase the risk of retinal vein occlusion include: High blood pressure. High cholesterol/high lipid levels. Raised pressure in the eye (glaucoma). Diabetes. Smoking. Conditions which 'thicken' the blood. What are the symptoms of retinal vein occlusion. If you have retinal vein occlusion, you will usually notice a decrease in.

Patient information leaflet
Can I take Apixaban and Rybelsus together?
These two medicines work in different ways and do not typically interfere with how the other is absorbed, broken down, or removed from the body. Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus is a GLP-1 receptor agonist used for type 2 diabetes that mimics a natural.
Further reading and references
- complement factor H; MedlinePlus, National Library of Medicine.
- Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF, Hageman GS, Smith RJ. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet. 2006 Jul;43(7):582-9. doi: 10.1136/jmg.2005.038315. Epub 2005 Nov 18.
- Atkinson JP, Goodship TH. Complement factor H and the hemolytic uremic syndrome. J Exp Med. 2007 Jun 11;204(6):1245-8. doi: 10.1084/jem.20070664. Epub 2007 Jun 4.
- Boon CJ, Klevering BJ, Hoyng CB, Zonneveld-Vrieling MN, Nabuurs SB, Blokland E, Cremers FP, den Hollander AI. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet. 2008 Feb;82(2):516-23. doi: 10.1016/j.ajhg.2007.11.007.
- Boon CJ, van de Kar NC, Klevering BJ, Keunen JE, Cremers FP, Klaver CC, Hoyng CB, Daha MR, den Hollander AI. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol. 2009 May;46(8-9):1573-94. doi: 10.1016/j.molimm.2009.02.013. Epub 2009 Mar 17.
- Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006 Jul 19;296(3):301-9. doi: 10.1001/jama.296.3.301.
- Donoso LA, Vrabec T, Kuivaniemi H. The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol. 2010 May-Jun;55(3):227-46. doi: 10.1016/j.survophthal.2009.11.001.
- Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, Klein ML. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One. 2007 Nov 28;2(11):e1197. doi: 10.1371/journal.pone.0001197.
- Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS, Li Y, Liang L, Zareparsi S, Swaroop A, Abecasis GR. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006 Sep;38(9):1049-54. doi: 10.1038/ng1871. Epub 2006 Aug 27.
- Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grunfeld JP, Niaudet P, Lesavre P, Fremeaux-Bacchi V. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.
- Xiao X, Pickering MC, Smith RJ. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. Semin Thromb Hemost. 2014 Jun;40(4):465-71. doi: 10.1055/s-0034-1376334. Epub 2014 May 5.
- Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Cordoba SR, Noris M, Pickering M, Smith R. The role of complement in C3 glomerulopathy. Mol Immunol. 2015 Sep;67(1):21-30. doi: 10.1016/j.molimm.2015.03.012. Epub 2015 Apr 28.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

